Literature DB >> 3491992

Selective killing of T lymphocytes by phototoxic liposomes.

S Yemul, C Berger, A Estabrook, S Suarez, R Edelson, H Bayley.   

Abstract

Two-fold specificity in drug delivery obtained through the localized activation of drugs by physical means and the attachment of drugs to proteins that bind to target cells might be used for highly selective cancer chemotherapy or for immunosuppression. Toward this end, a monoclonal antibody against an antigen on the surface of T lymphocytes was covalently attached to liposomes containing a phototoxic drug, pyrene, bound to the lipid bilayer. When unfractionated peripheral blood lymphocytes, or B- and T-cell lines, were irradiated after treatment with these liposomes, T cells were killed while B cells were spared, demonstrating the validity of the approach in a simple in vitro assay.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3491992      PMCID: PMC304180          DOI: 10.1073/pnas.84.1.246

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  37 in total

1.  A monoclonal antibody with selective reactivity with functionally mature human thymocytes and all peripheral human T cells.

Authors:  E L Reinherz; P C Kung; G Goldstein; S F Schlossman
Journal:  J Immunol       Date:  1979-09       Impact factor: 5.422

2.  Human T lymphocyte subpopulations: correlation between E-rosette-forming affinity and expression of the Fc receptor.

Authors:  W H West; S M Payne; J L Weese; R B Herberman
Journal:  J Immunol       Date:  1977-08       Impact factor: 5.422

3.  Design of liposomes for enhanced local release of drugs by hyperthermia.

Authors:  M B Yatvin; J N Weinstein; W H Dennis; R Blumenthal
Journal:  Science       Date:  1978-12-22       Impact factor: 47.728

4.  Morphological observations on the cellular and subcellular destination of intravenously administered liposomes.

Authors:  A W Segal; E J Wills; J E Richmond; G Slavin; C D Black; G Gregoriadis
Journal:  Br J Exp Pathol       Date:  1974-08

Review 5.  Laser biology and medicine.

Authors:  V S Letokhov
Journal:  Nature       Date:  1985 Jul 25-31       Impact factor: 49.962

6.  Immunomagnetic removal of CALLA positive cells from human bone marrow.

Authors:  C H Poynton; K A Dicke; S Culbert; L S Frankel; S Jagannath; C L Reading
Journal:  Lancet       Date:  1983-03-05       Impact factor: 79.321

7.  Immunotoxins: a new approach to cancer therapy.

Authors:  E S Vitetta; K A Krolick; M Miyama-Inaba; W Cushley; J W Uhr
Journal:  Science       Date:  1983-02-11       Impact factor: 47.728

8.  Use of monoclonal antibodies and liposomes to improve drug delivery. Present status and future implications.

Authors:  G Gregoriadis
Journal:  Drugs       Date:  1982-10       Impact factor: 9.546

9.  Photoimmunotherapy: treatment of animal tumors with tumor-specific monoclonal antibody-hematoporphyrin conjugates.

Authors:  D Mew; C K Wat; G H Towers; J G Levy
Journal:  J Immunol       Date:  1983-03       Impact factor: 5.422

10.  Protein thiolation and reversible protein-protein conjugation. N-Succinimidyl 3-(2-pyridyldithio)propionate, a new heterobifunctional reagent.

Authors:  J Carlsson; H Drevin; R Axén
Journal:  Biochem J       Date:  1978-09-01       Impact factor: 3.857

View more
  9 in total

1.  Phototoxic liposomes coupled to an antibody that alone cannot modulate its cell-surface antigen kill selected target cells.

Authors:  S Yemul; C Berger; M Katz; A Estabrook; R Edelson; H Bayley
Journal:  Cancer Immunol Immunother       Date:  1990       Impact factor: 6.968

2.  Luminescent oxygen channeling immunoassay: measurement of particle binding kinetics by chemiluminescence.

Authors:  E F Ullman; H Kirakossian; S Singh; Z P Wu; B R Irvin; J S Pease; A C Switchenko; J D Irvine; A Dafforn; C N Skold
Journal:  Proc Natl Acad Sci U S A       Date:  1994-06-07       Impact factor: 11.205

Review 3.  Antibody-targeted polymer-bound drugs.

Authors:  B Ríhová
Journal:  Folia Microbiol (Praha)       Date:  1995       Impact factor: 2.099

4.  Impacting Pancreatic Cancer Therapy in Heterotypic in Vitro Organoids and in Vivo Tumors with Specificity-Tuned, NIR-Activable Photoimmunonanoconjugates: Towards Conquering Desmoplasia?

Authors:  Girgis Obaid; Shazia Bano; Srivalleesha Mallidi; Mans Broekgaarden; Jerrin Kuriakose; Zachary Silber; Anne-Laure Bulin; Yucheng Wang; Zhiming Mai; Wendong Jin; Diane Simeone; Tayyaba Hasan
Journal:  Nano Lett       Date:  2019-10-04       Impact factor: 11.189

Review 5.  Mechanistic insights into extracorporeal photochemotherapy: efficient induction of monocyte-to-dendritic cell maturation.

Authors:  Richard L Edelson
Journal:  Transfus Apher Sci       Date:  2013-08-08       Impact factor: 1.764

6.  Photosensitized destruction of human bladder carcinoma cells treated with chlorin e6-conjugated microspheres.

Authors:  R Bachor; C R Shea; R Gillies; T Hasan
Journal:  Proc Natl Acad Sci U S A       Date:  1991-02-15       Impact factor: 11.205

Review 7.  Photopheresis: a new therapeutic concept.

Authors:  R L Edelson
Journal:  Yale J Biol Med       Date:  1989 Nov-Dec

8.  Specific targeting and toxicity of sulphonated aluminium phthalocyanine photosensitised liposomes directed to cells by monoclonal antibody in vitro.

Authors:  J Morgan; A G Gray; E R Huehns
Journal:  Br J Cancer       Date:  1989-03       Impact factor: 7.640

9.  Extracorporeal photochemotherapy induces bona fide immunogenic cell death.

Authors:  Kazuki Tatsuno; Takahiro Yamazaki; Douglas Hanlon; Patrick Han; Eve Robinson; Olga Sobolev; Alp Yurter; Felix Rivera-Molina; Najla Arshad; Richard L Edelson; Lorenzo Galluzzi
Journal:  Cell Death Dis       Date:  2019-08-02       Impact factor: 8.469

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.